Lifeline Drugs & Pharma has informed that the board of directors of the company at its meeting held on August 28, 2012, has approved issue and allotment up to 11,36,000 equity shares of face value of Rs. 10 each to non-promoters subject to the approval of shareholders in forthcoming EOGM. The price of issue of equity shares will be in accordance with the provisions of SEBI (Issue of Capital & Disclosure Requirement) Regulations, 2009 and the relevant date for the above purpose is August 24, 2012.
Further, the board will convene extra ordinary general meeting (EOGM) of the members of the company on September 25, 2012, seeking their approval for above businesses
The above information is a part of company's filings submitted to BSE.
